CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ NYESO-1-Specific T Cells and the NY-ESO-1 Immunostimulatory Agents LV305 or CMB305 for Patients With Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03450122
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:31.454153+00:00
Published At: 2023-10-16T00:00:00+00:00
Record Updated At: 2023-10-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HLA-A*0201 Positive Cells Present", "NY-ESO-1 Positive Tumor Cells Present", "Recurrent Myxoid Liposarcoma", "Recurrent Synovial Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-16"
protocolSection.identificationModule.nctId: "NCT03450122"
protocolSection.identificationModule.officialTitle: "Phase I Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ NYESO-1-Specific T Cells and the NY-ESO-1 Immunostimulatory Agents LV305 or CMB305 for Patients With Sarcoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.